New-onset psoriasis with abrocitinib therapy for atopic dermatitis
Saved in:
| Main Authors: | Sarah L. Becker, BA, Adeeb Haroon, MD, Eric Simpson, MD, MCR |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512625001602 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vitiligo exacerbation during upadacitinib treatment for atopic dermatitis and improvement following a switch to abrocitinib: a case report
by: Zhaoyang Wang, et al.
Published: (2025-12-01) -
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE
by: Jonathan I. Silverberg, et al.
Published: (2025-02-01) -
The impact of abrocitinib treatment on lesion area and pruritus in patients with atopic dermatitis: a systematic review and meta-analysis
by: Xiao-Li Kou, et al.
Published: (2025-07-01) -
Abrocitinib Treatment for Localized Type of Generalized Pustular Psoriasis: A Case Report
by: Yang Z, et al.
Published: (2025-03-01) -
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
by: Francesca Barei, et al.
Published: (2024-12-01)